Additional Information


Content

Public Relations: Skin-cancer label taps Ogilvy unit

SYDNEY: Parker & Partners, the public affairs arm of Ogilvy & Mather has been charged with launching Aldara, a skin-cancer treatment by 3M Pharmaceuticals. As well as promoting awareness of the product to mainstream media and specialist titles, Parker & Partners will be lobbying the Government to list the product on its pharmaceutical benefits scheme.

Share this article

The prescription only cream, which must be recommended by a dermatologist or GP, works by prompting the body's own immune system to destroy the cancerous cells and experts say it could save about 50,000 Australians a year from painful surgical incisions.

"Australia has some pretty strong rules about promoting pharmaceuticals, but at P&P we have a deep understanding of the code of conduct. You can promote the educational benefits of the product and how patients can get more information about it, rather than promoting the product itself," said P&P managing director Andrew Parker.

The business was won in a pitch against a number of undisclosed agencies, with P&P launching the product to the media this month. Australia has the world's highest skin cancer rate, which means although there is genuine interest in the topic, it can be over-exposed.

This article was first published on Media Asia

More about

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Additional Information

Latest jobs Jobs web feed

FROM THE BLOGS

The Wall blogs

Back to top ^